Orthopedic device company RTI Surgical partnered with Exactech to develop and supply biologic bone grafts.
Biologics
Orthopedic surgeon Scott Rodeo, MD, of New York City-based Hospital for Special Surgery received a $50,000 grant from the Orthopaedic Research and Education Foundation to study an injectable knee biologic.
Lawsuits on behalf of a Florida woman and a Delaware man were filed against Aziyo Biologics after they received a tainted FiberCel implant.
Orthopedic device company Arthrex struck a deal with Celularity to distribute biomaterial products for orthopedic surgery, according to a July 1 news release.
The number of patients treated for tuberculosis after undergoing spine surgery with FiberCel, a bone matrix allograft, is growing.
Advertisement
Ortho Regenerative Technologies named Howard Walthall and Tim Cunningham to its board of directors, the company said June 15.
The FDA is ramping up enforcement activities against companies developing unapproved stem cell therapies, particularly for spine and orthopedic indications, according to the Regulatory Affairs Professional Society.
Ortho Regenerative Technologies received a clinical hold letter from the FDA related to its trial for its hybrid implant, Ortho-R, the company said June 4.
Adipose cells, commonly known as fat, could be a useful source of stem cells to promote bone growth in spinal fusion, according to researchers from Johns Hopkins Medicine in Baltimore.
The FDA has granted breakthrough device designation for Cerapedics' P-15L bone graft for the treatment of degenerative disc disease.